Michael Weichenthal
0000-0002-9060-4961
University Hospital Schleswig-Holstein
4 papers found
Refreshing results…
Characterisation and outcome of RAC1 mutated melanoma
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Missing publications? Search for publications with a matching author name.